Browse: Departments Dates Agencies
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
NOTICE: NOTICES
ACTION: Meetings:
SUBJECT CATEGORY: National Cancer Institute; Notice of Closed Meetings
DOCUMENT SUMMARY:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis Panel, Cooperative Human Tissue Network.
Date: January 16, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817.
Contact Person: C. Michael Kerwin, PhD, MPH., Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 6116
Executive Blvd., Rm. 8057, Bethesda, MD 208928329, 3014967421,
kerwinm@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel, Discovery and Development.
Date: February 68, 2008.
Time: 8 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Peter J. Wirth, PhD, Scientific Review
Administrator, Research Programs Review Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Boulevard, Room 8131, Bethesda, MD 208928328, 3014967565,
pw2q@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Advances in Protein Expression of PostTranslationally Modified Cancer Related Proteins.
Date: February 28, 2008.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6130 Executive Blvd., Conference Room F, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Marvin L. Salin, PhD, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Boulevard, Room 7073, Bethesda, MD 208928329, 3014960694,
msalin@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel, Innovative Technologies for Molecular Analysis of Cancer.
Date: March 56, 2008.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Crowne Plaza Rockville, 3 Research Court, Rockville, MD 20850.
Contact Person: Jeffrey E. DeClue, PhD, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Boulevard, Room 8059, Bethesda, MD 208928329, 3014967904,
decluej@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)
Dated: December 19, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 076215 Filed 122707; 8:45 am]
BILLING CODE 414001M
SUMMARY: National Cancer Institute,
DOCUMENT BODY 2:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis Panel, Cooperative Human Tissue Network.
Date: January 16, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817.
Contact Person: C. Michael Kerwin, PhD, MPH., Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 6116
Executive Blvd., Rm. 8057, Bethesda, MD 208928329, 3014967421,
kerwinm@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel, Discovery and Development.
Date: February 68, 2008.
Time: 8 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Peter J. Wirth, PhD, Scientific Review
Administrator, Research Programs Review Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Boulevard, Room 8131, Bethesda, MD 208928328, 3014967565,
pw2q@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Advances in Protein Expression of PostTranslationally Modified Cancer Related Proteins.
Date: February 28, 2008.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6130 Executive Blvd., Conference Room F, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Marvin L. Salin, PhD, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Boulevard, Room 7073, Bethesda, MD 208928329, 3014960694,
msalin@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel, Innovative Technologies for Molecular Analysis of Cancer.
Date: March 56, 2008.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Crowne Plaza Rockville, 3 Research Court, Rockville, MD 20850.
Contact Person: Jeffrey E. DeClue, PhD, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Boulevard, Room 8059, Bethesda, MD 208928329, 3014967904,
decluej@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)
Dated: December 19, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 076215 Filed 122707; 8:45 am]
BILLING CODE 414001M
Common CFR Searches
14 CFR Part 39 40 CFR Part 52 14 CFR Part 71 33 CFR Part 165 50 CFR Part 679 26 CFR Part 1 40 CFR Part 180 47 CFR Part 73 50 CFR Part 17 33 CFR Part 117 44 CFR Part 67 50 CFR Part 648 14 CFR Part 97 33 CFR Part 100 40 CFR Part 63 50 CFR Part 622 26 CFR Part 301 39 CFR Part 111 40 CFR Part 300 50 CFR Part 660 44 CFR Part 65 40 CFR Parts 52 and 81 40 CFR Part 271 47 CFR Part 64 50 CFR Part 665 47 CFR Part 76 50 CFR Part 229 14 CFR Part 23 14 CFR Part 25 21 CFR Part 522